000 01184nam a2200301Ia 4500
001 ebr10188620
003 CaPaEBR
006 m u
007 cr cn|||||||||
008 930716s2007 ctua sb 001 0 eng d
020 _z9780444521736
020 _z9780080548241
040 _aCaPaEBR
_cCaPaEBR
035 _a(OCoLC)648316444
050 1 4 _aRM411
_b.A383 2007eb
245 0 0 _aAdvances in antiviral drug design.
_nVolume 5
_h[electronic resource] /
_ceditor, E. De Clercq.
260 _aGreenwich, CT ;
_aLondon, England :
_bJai Press,
_c2007.
300 _axi, 251 p. :
_bill.
490 0 _aAdvances in antiviral drug design ;
_v5
504 _aIncludes bibliographical references and index.
533 _aElectronic reproduction.
_bPalo Alto, Calif. :
_cebrary,
_d2013.
_nAvailable via World Wide Web.
_nAccess may be limited to ebrary affiliated libraries.
650 0 _aAntiviral agents.
650 0 _aAnti-infective agents.
655 7 _aElectronic books.
_2local
700 1 _aDe Clercq, Erik.
710 2 _aebrary, Inc.
856 4 0 _uhttp://site.ebrary.com/lib/rucke/Doc?id=10188620
_zAn electronic book accessible through the World Wide Web; click to view
999 _c149036
_d149036